Description
A Na+/K+-ATPase inhibitor; cardiac glycoside metabolite of digoxin; has a binding affinity of 0.829 relative to [3H]ouabain; has an inhibitory potency of 1.07 relative to [3H]ouabain for its ATPase activity; selective for the α3β1 isoform over α1β1 and α2β1 (Kds = 31.8, 65, and 35 nM, respectively); produces a more potent inotropic response in perfused guinea pig hearts than digoxin (60 and 46% increases in inotropy, respectively)
Formal name: (3β,5β,12β)-3-[(2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-card-20(22)-enolide
Synonyms:
Molecular weight: 520.7
CAS: 5352-63-6
Purity: ≥97%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|ATPases||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Heart|Myocardial Contractility